TY - JOUR
T1 - ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas
AU - Wilder-Smith, Annelies
AU - Preet, Raman
AU - Brickley, Elizabeth B
AU - Ximenes, Ricardo Arraes de Alencar
AU - Miranda-Filho, Demócrito de Barros
AU - Turchi Martelli, Celina Maria
AU - Araújo, Thália Velho Barreto de
AU - Montarroyos, Ulisses Ramos
AU - Moreira, Maria Elisabeth
AU - Turchi, Marília Dalva
AU - Solomon, Tom
AU - Jacobs, Bart C
AU - Villamizar, Carlos Pardo
AU - Osorio, Lyda
AU - de Filipps, Ana Maria Bispo
AU - Neyts, Johan
AU - Kaptein, Suzanne
AU - Huits, Ralph
AU - Ariën, Kevin
AU - Willison, Hugh J
AU - Edgar, Julia M
AU - Barnett, Susan C
AU - Peeling, Rosanna
AU - Boeras, Debi
AU - Guzman, Maria G
AU - de Silva, Aravinda M
AU - Falconar, Andrew K
AU - Romero-Vivas, Claudia
AU - Gaunt, Michael W
AU - Sette, Alessandro
AU - Weiskopf, Daniela
AU - Lambrechts, Louis
AU - Dolk, Helen
AU - Morris, Joan K
AU - Orioli, Ieda M
AU - O'Reilly, Kathleen M
AU - Yakob, Laith
AU - Rocklöv, Joacim
AU - Soares, Cristiane
AU - Ferreira, Maria Lúcia Brito
AU - Franca, Rafael Freitas de Oliveira
AU - Precioso, Alexander R
AU - Logan, James
AU - Lang, Trudie
AU - Jamieson, Nina
AU - Massad, Eduardo
N1 - FTX; DOAJ; (CC BY 4.0)
PY - 2019
Y1 - 2019
N2 - Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network.
AB - Zika Preparedness Latin American Network (ZikaPLAN) is a research consortium funded by the European Commission to address the research gaps in combating Zika and to establish a sustainable network with research capacity building in the Americas. Here we present a report on ZikaPLAN`s mid-term achievements since its initiation in October 2016 to June 2019, illustrating the research objectives of the 15 work packages ranging from virology, diagnostics, entomology and vector control, modelling to clinical cohort studies in pregnant women and neonates, as well as studies on the neurological complications of Zika infections in adolescents and adults. For example, the Neuroviruses Emerging in the Americas Study (NEAS) has set up more than 10 clinical sites in Colombia. Through the Butantan Phase 3 dengue vaccine trial, we have access to samples of 17,000 subjects in 14 different geographic locations in Brazil. To address the lack of access to clinical samples for diagnostic evaluation, ZikaPLAN set up a network of quality sites with access to well-characterized clinical specimens and capacity for independent evaluations. The International Committee for Congenital Anomaly Surveillance Tools was formed with global representation from regional networks conducting birth defects surveillance. We have collated a comprehensive inventory of resources and tools for birth defects surveillance, and developed an App for low resource regions facilitating the coding and description of all major externally visible congenital anomalies including congenital Zika syndrome. Research Capacity Network (REDe) is a shared and open resource centre where researchers and health workers can access tools, resources and support, enabling better and more research in the region. Addressing the gap in research capacity in LMICs is pivotal in ensuring broad-based systems to be prepared for the next outbreak. Our shared and open research space through REDe will be used to maximize the transfer of research into practice by summarizing the research output and by hosting the tools, resources, guidance and recommendations generated by these studies. Leveraging on the research from this consortium, we are working towards a research preparedness network.
KW - Zika
KW - congenital Zika syndrome
KW - birth defect
KW - epidemic preparedness
KW - research capacity building
KW - European Commission
KW - microcephaly
KW - Guillain-Barr? syndrome
KW - encephalitis
KW - sustainability
KW - GUILLAIN-BARRE-SYNDROME
KW - VIRUS-INFECTION
KW - TRAVELERS
KW - BRAZIL
KW - EPIDEMIOLOGY
KW - SURVEILLANCE
KW - TRANSMISSION
KW - DIAGNOSIS
KW - OUTBREAK
KW - HISTORY
U2 - 10.1080/16549716.2019.1666566
DO - 10.1080/16549716.2019.1666566
M3 - A1: Web of Science-article
C2 - 31640505
SN - 1654-9880
VL - 12
JO - Global Health Action
JF - Global Health Action
IS - 1
M1 - 1666566
ER -